Clinical Trials Directory

Trials / Completed

CompletedNCT03905928

Establishing the Effect of Flavor on the Addictive Potential of Electronic Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

The current study aims to establish proof-of-concept that neural cue-reactivity can serve as an early, objective marker of electronic cigarette (ECIG) addictive potential. Further, this study will examine the effect of flavor and nicotine concentration on the addictive potential of ECIGs to aid research informing U.S. Food and Drug Administration (FDA) flavor regulations and smoking cessation.

Conditions

Interventions

TypeNameDescription
OTHERNicotine Containing ECIG with tobacco flavorParticipants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a "vape pen-style" device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 18mg/ml nicotine concentration and a tobacco flavor.
OTHERNicotine Containing ECIG with Strawberry Vanilla FlavorParticipants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a "vape pen-style" device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 18mg/ml nicotine concentration and a strawberry vanilla flavor.
OTHERPlacebo ECIG with Tobacco FlavorParticipants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a "vape pen-style" device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 0mg/ml nicotine concentration and a tobacco flavor.
OTHERPlacebo ECIG with Strawberry Vanilla FlavorParticipants will be provided with an EGO style ECIG to be used for 28 days. The EGO style ECIG is a "vape pen-style" device that comprises of a rechargeable battery and a tank containing liquid. Those in this intervention group will receive an ECIG with 0mg/ml nicotine concentration and a strawberry vanilla flavor.

Timeline

Start date
2019-11-04
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2019-04-08
Last updated
2025-06-22
Results posted
2025-06-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03905928. Inclusion in this directory is not an endorsement.